MYK-491

· MyoKardia, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MYK-491, covering 2018-03-23 to 2023-02-02. Get the full timeline:

Most recent: Clinical Trial Update: v4 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491 [Phase 1, Phase 2]

See pricing